Lorzone
Pricing Report NDC 68025-047-10

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Lorzone (NDC 68025-047-10) is $10.56837 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 01, 2021.

As a provided by Vertical Pharmaceuticals, Inc., this medication is distributed in a 100 TABLET in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$10.56837
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jan 01, 2021
Billable Units
100 EA
Estimated Package Price
$1,056.84
Data Status
As of Jan 12, 2022
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B-ANDA - Abbreviated New Drug Application
Package NDC
68025-047-10
Description
100 TABLET in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2013, the NADAC wholesale price for (NDC ) has moved within a range of $4.33072 to $10.56837 per EA. Over this 7 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$4.3307 - $10.5684
Market Volatility
144.03% Variance
Latest Trend
8.00%
Date Unit Price Unit Source Method Rate
Jan 01, 2021 $10.56837 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Jan 01, 2021 $10.56837 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Jan 01, 2020 $9.78553 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Jan 01, 2020 $9.78553 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Mar 08, 2019 $8.90403 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Mar 08, 2019 $8.90403 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Mar 08, 2019 $8.90403 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Nov 21, 2018 $8.10194 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Nov 21, 2018 $8.10194 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Jan 01, 2018 $8.13414 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Jan 01, 2018 $8.13414 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Jan 01, 2018 $8.13414 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Dec 20, 2017 $7.60193 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Feb 03, 2017 $7.53208 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Feb 03, 2017 $7.53208 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Feb 03, 2017 $7.53208 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
May 18, 2016 $6.85357 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
May 18, 2016 $6.85357 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Feb 17, 2016 $7.01634 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Feb 17, 2016 $7.01634 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Jan 08, 2016 $6.85324 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Jul 02, 2015 $6.40490 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Jul 02, 2015 $6.40490 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Jan 09, 2015 $5.69324 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Jan 09, 2015 $5.69324 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Jan 09, 2015 $5.69324 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Mar 03, 2014 $5.19682 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Mar 03, 2014 $5.19682 EAC/I - Chain or Independent PharmacyCode 3, 6B-ANDA - Abbreviated New Drug Application
Mar 03, 2014 $5.19682 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Aug 02, 2013 $4.33072 EAC/I - Chain or Independent PharmacyCode 2, 6B-ANDA - Abbreviated New Drug Application
Aug 02, 2013 $4.33072 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026